At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 44 enrolled
Drug / intervention
Morphine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Morphine
University of Texas Southwestern Medical Center·interventional·Posted Oct 24, 2019·Updated Jan 12, 2023
In Brief
A Phase 2 clinical trial evaluating Morphine and Placebo for Healthy. Completed, enrolled 44 participants across 1 site.
Detailed Summary
We are examining how morphine (a commonly used pain medication) will alter responses to simulated blood loss in humans. To simulate blood loss in our research laboratory, participants will complete a test with their lower body in a custom-designed vacuum chamber for a brief period of time.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartNov 2019
Primary CompletionJan 2022
TodayJul 2026
First PostedOct 24, 2019
Enrollment StartNov 12, 2019
Primary CompletionJan 4, 2022
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 6.7 years ago
Interventions
Morphinedrug
Subjects will receive Morphine while the effects of this drug on tolerance to a hemorrhagic insult will be assessed.
Placeboother
Subjects will receive saline while the effects of this drug on tolerance to a hemorrhagic insult will be assessed.